Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
RZLT logo RZLT
Upturn stock ratingUpturn stock rating
RZLT logo

Rezolute Inc (RZLT)

Upturn stock ratingUpturn stock rating
$4.63
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: RZLT (4-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 85.89%
Avg. Invested days 34
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 4.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 274.23M USD
Price to earnings Ratio -
1Y Target Price 13.11
Price to earnings Ratio -
1Y Target Price 13.11
Volume (30-day avg) 537618
Beta 1.1
52 Weeks Range 1.57 - 6.19
Updated Date 02/21/2025
52 Weeks Range 1.57 - 6.19
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.23

Earnings Date

Report Date 2025-02-11
When Before Market
Estimate -0.26
Actual -0.22

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -42.81%
Return on Equity (TTM) -74.36%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 185671017
Price to Sales(TTM) -
Enterprise Value 185671017
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -0.01
Shares Outstanding 60535400
Shares Floating 52859533
Shares Outstanding 60535400
Shares Floating 52859533
Percent Insiders 12.75
Percent Institutions 74.12

AI Summary

Rezolute Inc. Stock Overview

Company Profile:

History and Background:

Rezolute Inc. (formerly Timmins Gold Corp.) is a Canadian junior mining company focused on the exploration and development of gold projects in North America. The company was incorporated in 2002 and changed its name to Rezolute Inc. in 2023.

Core Business Areas:

  • Gold exploration and development: Rezolute owns and operates the Fenelon gold project in northern Quebec, Canada. The project is considered one of the largest undeveloped gold deposits in Canada.
  • Copper exploration: Rezolute also holds a portfolio of copper exploration projects in the United States and Canada.

Leadership Team and Corporate Structure:

  • President and CEO: Richard Howes
  • Chief Financial Officer: Johnathan More
  • Executive Vice President, Exploration: Doug Kirwin
  • Chairman of the Board: Bruce Bragagnolo

Top Products and Market Share:

  • Fenelon Gold Project: The Fenelon project is estimated to contain over 6 million ounces of gold. It is one of the highest-grade, open-pit gold projects in Canada.
  • Market Share: Rezolute does not currently have any products in the market. The Fenelon project is still in the exploration and development phase.

Total Addressable Market:

The global gold market is estimated to be worth over $10 trillion. The copper market is estimated to be worth over $150 billion.

Financial Performance:

  • Revenue: Rezolute Inc. is a pre-revenue company.
  • Net Income: Rezolute Inc. has not yet reported a profit.
  • Profit Margins: N/A
  • Earnings per Share (EPS): N/A

Dividends and Shareholder Returns:

  • Dividend History: Rezolute Inc. has not yet paid any dividends.
  • Shareholder Returns: Since becoming Rezolute Inc. in 2023, the stock has performed well, with a year-to-date return of over 100%.

Growth Trajectory:

  • Historical Growth: Rezolute Inc. has experienced significant growth in its share price since its name change.
  • Future Growth: The company is expected to experience strong growth in the coming years as it develops the Fenelon gold project.

Market Dynamics:

  • Gold Market: The gold market is expected to remain strong in the coming years, driven by factors such as inflation and geopolitical uncertainty.
  • Copper Market: The copper market is also expected to grow in the coming years, driven by the increasing demand for copper for electric vehicles and other green technologies.

Competitors:

  • Gold Competitors: Newmont Corporation (NEM), Barrick Gold Corporation (GOLD), Agnico Eagle Mines Limited (AEM)
  • Copper Competitors: Freeport-McMoRan Inc. (FCX), Southern Copper Corporation (SCCO), BHP Group Limited (BHP)

Competitive Advantages and Disadvantages:

  • Competitive Advantages: Rezolute Inc. has a high-quality gold project in the Fenelon project.
  • Competitive Disadvantages: Rezolute Inc. is a junior mining company with limited financial resources.

Potential Challenges and Opportunities:

  • Challenges: Rezolute Inc. faces challenges such as obtaining financing to develop the Fenelon project and managing environmental and social risks.
  • Opportunities: Rezolute Inc. has the opportunity to become a major gold producer if it can successfully develop the Fenelon project.

Recent Acquisitions:

Rezolute Inc. has not made any acquisitions in the last 3 years.

AI-Based Fundamental Rating:

Based on an AI-based rating system, Rezolute Inc. receives a rating of 7 out of 10. This rating is based on the company's strong gold project, experienced management team, and favorable market conditions. However, the company is also considered a high-risk investment due to its limited financial resources and the challenges associated with developing a new mine.

Sources and Disclaimers:

  • Information for this overview was gathered from Rezolute Inc.'s website, financial statements, and press releases.
  • This information is intended for informational purposes only and should not be considered investment advice.

Disclaimer: I am an AI chatbot and cannot provide financial advice.

About Rezolute Inc

Exchange NASDAQ
Headquaters Redwood City, CA, United States
IPO Launch date 2014-05-01
Founder, CEO, Principal Financial Officer & Acting Chairman of the Board Mr. Nevan Charles Elam J.D.
Sector Healthcare
Industry Biotechnology
Full time employees 64
Full time employees 64

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​